Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics.

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

Longitudinal assessment of circulating insulin-like peptide 3 levels in healthy peripubertal girls  Casper P. Hagen, Ph.D., Mikkel G. Mieritz, M.D., John.
Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization  Martin D. Keltz,
A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer  Claudine C Hunault, M.D., Marinus J.C.
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis  Ouijdane Hamdine,
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison 
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve  László F.J.M.M Bancsi,
Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study  Arianna D'Angelo, M.D., Rachel.
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Patient-tailored ovarian stimulation for in vitro fertilization
Urinary reproductive hormone level differences between African American and Caucasian women of reproductive age  Susan R Reutman, Ph.D., Grace Kawas LeMasters,
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients  N. Ellissa Baskind, M.B.Ch.B.,
Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization.
Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective.
Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF  John Y Phelps, M.D., Adam S Levine,
Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age  Sanja Kupesic, M.D., Ph.D., Asim Kurjak,
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
A comparison of blood spot vs
Occurrence of postmenopausal-like acidic follicle-stimulating hormone (FSH) isoforms precedes the rise of FSH before menopause  Chris M.G. Thomas, Ph.D.,
Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A
Robert F. Casper, M.D.  Fertility and Sterility 
Albert Hsu, M. D. , Margaret Arny, Ph. D. , Alexander B. Knee, M. S
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study  Donald Tredway, M.D., Ph.D.,
Angela R Baerwald, B. Sc. Hon. , Gregg P Adams, D. V. M. , M. S. , Ph
Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1 
Vivian Barak, Ph. D. , Uriel Elchalal, M. D. , Michal Edelstein, M. D
René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Endometrial wavelike activity, endometrial thickness, and ultrasound texture in controlled ovarian hyperstimulation cycles  Marga M IJland, M.D., Johannes.
Nadine M. P. Daan, Annemieke Hoek, Eva Corpeleijn, Marinus J. C
Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision- analytic model  Lobke M. Moolenaar, M.D., Frank J.M. Broekmans,
Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating.
Perimenstrual asthma: A syndrome without known cause or cure
Mean versus individual hormonal profiles in the menstrual cycle
The additional value of ovarian hyperstimulation in intrauterine insemination for couples with an abnormal postcoital test and a poor prognosis: a randomized.
Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.
Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.
Clazien A. M. Bouwmans, M. Sc. , Bea M. E. Lintsen, M. D. , Marinus J
Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis  Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization–embryo transfer.
Percutaneous oocyte retrieval from an inguinal ovary
High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model.
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
Analysis of follicular fluid hormone concentrations and granulosa cell mRNA levels for the inhibin-activin-follistatin system: relation to oocyte and.
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility  Joop S.E Laven, Ph.D., Annemarie G.M.G.J.
Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles  David.
Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study  Donald Tredway,
Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?  Nadine M.P. Daan, M.D., Yvonne V.
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility 
Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect.
Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility:
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization  Luca Sabatini,
Presentation transcript:

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging  Nicole G.M. Beckers, M.D., Nicholas S. Macklon, Ph.D., Marinus J.C. Eijkemans, M.Sc., Bart C.J.M. Fauser, Ph.D.  Fertility and Sterility  Volume 78, Issue 2, Pages 291-297 (August 2002) DOI: 10.1016/S0015-0282(02)03227-2

FIGURE 1 The number of antral follicles present throughout the follicular phase is shown. The grey area depicts the 25th- and 75th-percentile amounts of the healthy controls, the black lines depict median and 25th- and 75th-percentile amounts of poor responders. Beckers. The follicular phase in poor responders. Fertil Steril 2002. Fertility and Sterility 2002 78, 291-297DOI: (10.1016/S0015-0282(02)03227-2)

FIGURE 2 Follicular phase serum levels of FSH, LH, E2, and P. The gray areas depict the 25th- and 75th-percentile levels of the healthy controls; the black lines depict median and 25th- and 75th-percentile levels of poor responders. Beckers. The follicular phase in poor responders. Fertil Steril 2002. Fertility and Sterility 2002 78, 291-297DOI: (10.1016/S0015-0282(02)03227-2)

FIGURE 3 The association between age and number of follicles overall and for poor responders (•) and healthy controls (○). The gray area indicates the overlap of age in the poor-responder and the healthy-control groups. Beckers. The follicular phase in poor responders. Fertil Steril 2002. Fertility and Sterility 2002 78, 291-297DOI: (10.1016/S0015-0282(02)03227-2)